1-20 of 43
Emmanuelle Nicolas Virelizier, MD
Close
Sort by
Journal Articles

Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

Mauricette Michallet, MD PhD, Romain Buono, PharmD, Mohamad Sobh, PharmD, Solene Poirey, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, MD, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Aude Flechon, MD PhD, Helen Boyle, MD, Franck E Nicolini, MDPhD, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-142355
Published: 2020
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, MD PhD, Maya Hacini, MD, Kamal Bouabdallah, MD, Kamel Laribi, MD, Marie Maerevoet, MD, Loic Ysebaert, MD PhD, Stephanie Guidez, Steven Le Gouill, MD PhD, Marc André, MD, Jehan Dupuis, MD, Catherine Thieblemont, MD PhD, Emmanuel Bachy, MD PhD, Nicolas Daguindau, MD, Franck Morschhauser, MD PhD, Sabine Tricot, MD, Pierre Feugier, MD PhD, Anne Banos, MD, Thierry Lamy De La Chapelle, MD PhD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Guillaume Cartron, MD PhD, Hassan Farhat, MD, Vincent Camus, Bernard Drenou, MD PhD, Hacene Zerazhi, MD, David Sibon, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Caroline Delette, MD, Sylvia Snauwaert, MD, Nicole Straetmans, MD, Richard Delarue, MD, Marie Parrens, MD, Céline Bossard, MD, Laurence De Leval, MD, Philippe Gaulard, MD PhD, Gandhi Laurent Damaj, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139224
Published: 2020
Journal Articles

Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma

Marie-Charlotte Laude, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Gabriel Antherieu, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Fadhela Bouafia, MD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-138789
Published: 2020
Journal Articles

Retrospective Evaluation of Rituximab, Methotrexate, Procabazine, Vincristine and Etoposide Followed By Consolidation with Rituximab, Aracytine and Ifosfamide for Elderly Patients with Newly Diagnosed Primary CNS Lymphoma

Gabriel Antherieu, PhD, Edith Julia, Emmanuelle Nicolas-Virelizier, MD, Marie-Charlotte Laude, Violaine Safar, Philippe Rey, MD, Emmanuelle Ferrant, MD, Alexandra Traverse-Glehen, MD PhD, Catherine Chassagne-Clément, MD, David Meyronet, MD PhD, Anne Lazareth, MD, Helene Lequeu, MD, Camille Golfier, MD, Gabriel Brisou, MD, Dana Ghergus, MD, Pierre Sesques, MD, Lionel Karlin, MD, Fadhela Bouafia, MD, Gilles Salles, MDPhD, Emmanuel Bachy, MD PhD, François Ducray, MD PhD, Youenn Drouet, PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-139946
Published: 2020
Journal Articles

Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients

Amine Belhabri, MD, Liliana Vila, MD, Mael Heiblig, Stephane Morisset, BioStat, Emmanuelle Nicolas-Virelizier, MD, Clémence Santana, MD, Isabelle Tigaud, MD, Sandrine Hayette, PhD, Anne-Sophie Michallet, MD PhD, Philippe Rey, MD, Yann Guillermin, MD, Souad Assad, MD, Laure Lebras, MD, Mauricette Michallet, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-142956
Published: 2020
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Romain Buono, Solene Poirey, Isabela Pascu, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Lila Gilis, MD, Franck E Nicolini, MD PhD, Stephane Morisset, BioStat, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5817.
https://doi.org/10.1182/blood-2019-130597
Published: 2019
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Philippe Gaulard, MD PhD, Marc Andre, MD, Corinne Haioun, MD PhD, Romain Bosc, MD PhD, Camille Laurent, MD PhD, Lionel Tortelano, PD, Thua-Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Schiano de Colella Jean Marc, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Borhane Slama, MD, Luc Mathieu Fornecker, MD PhD, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Manon Croix, Julie Bonnefoy, Patrick Fogarty, Feriel Bouabbas, Nadia Amara, Virginie Fataccioli, PhD, Romain Ricci, Tania Cassubie-Mercier, Youlia Kirova, MD, Fabien Reyal, Herve Tilly, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Christophe Bonnet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4021.
https://doi.org/10.1182/blood-2019-129123
Published: 2019
Journal Articles

Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA)

Herve Ghesquieres, MD PhD, Olivier Casasnovas, MD, Emmanuelle Nicolas-Virelizier, MD, Damaj Gandhi Laurent, MD PhD, Vincent Delwail, MD, Mohamed Touati, MD, Katell Le Du, MD, Franck Morschhauser, MD PhD, Christophe Bonnet, MD, Agathe Waultier-Rascalou, MD, Frederique Orsini-Piocelle, MD, Marc André, Myriam Ben Boutieb, Fabienne Morand, Diane Damotte, MD PhD, Alexandra Traverse-Glehen, MD PhD, Philippe Quittet, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 2832.
https://doi.org/10.1182/blood-2019-129016
Published: 2019
Journal Articles

Ritumixab in Combination with Adapted-Dose of Ifosfamide and Etoposide As Salvage Treatment in Elderly Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for High Dose Therapy: A Retrospective Study of Lyon Hospital University

Guillaume Aussedat, Delphine Maucort-Boulch, MD PhD, Philippe Rey, MD, Violaine Safar, MD, Lionel Karlin, MD, Mad-Helenie Elsensohn, Msc, Laure Lebras, MD, Clementine Sarkozy, MD, Emmanuel Bachy, MD PhD, Bertrand Favier, PharmD, PhD, Nicolas Vantard, PharmD, Pierre Sesques, MD, Anne Lazareth, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Gilles Salles, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4215.
https://doi.org/10.1182/blood-2018-99-116734
Published: 2018
Journal Articles

A Phase II Lysa Study of Obinutuzumab Combined with Lenalidomide for Advanced Untretated Follicular B-Cell Lymphoma in Need of Systemic Therapy

Franck Morschhauser, MD, Gilles Andre Salles, Rene-Olivier Casasnovas, MD, Pierre Feugier, Krimo Bouabdallah, MD, Guillaume Cartron, Reda Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Marie Maerevoet, MD, Sylvia Snauwaert, Christophe Fruchart, Steven LE Gouill, MD PhD, Cécile Moluçon-Chabrot, MD PhD, Caroline Delette, Lysiane Molina, MD, Herve Tilly, MD, Catherine Thieblemont, MD, Eric Van Den Neste, Fontanet Bijou, MD, Bettina Fabiani, MD, Corinne Haioun, MD, Roch Houot, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 446.
https://doi.org/10.1182/blood-2018-99-112805
Published: 2018
Journal Articles

A New Simplified Prognostic Index Integrating the Type of Extra-Nodal Involvement and Age for Ann Arbor Stage IV Hodgkin Lymphoma Patients Diagnosed at TEP-Scanner Era: A Retrospective Analysis from Lymphoma Study Association (LYSA) Centers

Camille Golfier, Delphine Maucort-Boulch, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Cedric Rossi, MD, Pierre Sesques, MD, Nicolas Vantard, PharmD, Bertrand Favier, PharmD, PhD, Emmanuel Bachy, MD PhD, Florence Broussais-Guillaumot, MD, Emmanuelle Ferrant, MD, Dana Ghergus, MD, Lionel Karlin, MD, Anne Lazareth, MD, Violaine Safar, MD, Clementine Sarkozy, MD, Souad Assaad, MD, Laure Lebras, MD, Philippe Rey, MD, Jean-Noel Bastie, MD PhD, Alexandra Traverse-Glehen, MD PhD, Laurent Martin, MD PhD, Jeremie Tordo, MD, Alina Berriolo-Riedinger, MD, Gilles Salles, MD PhD, Rene-Olivier Casasnovas, MD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2018-99-118578
Published: 2018
Journal Articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program

Guillaume Manson, MD, Jean-Baptiste Mear, MD, Charles Herbaux, MD, Jean Marc Schiano de Collela, MD, Rene-Olivier Casasnovas, MD, Aspasia Stamatoullas, MD, Bénédicte Deau-Fisher, MD, Anna Schmitt, Georges Garnier, MD, Lysiane Molina, MD, Krimo Bouabdallah, MD, Marie-Pierre Moles, Herv Ghesquieres, Adrian Tempescul, MD, Remy Dulery, MD, Emmanuelle Nicolas-Virelizier, MD, Alain Jacques Delmer, MD, Cecile Borel, MD, Adrien Chauchet, MD, Laurent Dercle, MD, Pauline Brice, MD, Roch Houot, Pr, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1638.
https://doi.org/10.1182/blood-2018-99-110960
Published: 2018
Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The French Lymphoma Study Association (LYSA) Registry Data

Fabien Le Bras, Camille Laurent, MD PhD, Romain Bosc, MDPhD, Lionel Tortelano, PD, Tu Ha Dao, MD, Emmanuel Itti, MD PhD, Caroline Malhaire, MD, Jean Marc Schiano de Collela, MD, Marie Bannier, MD, Emmanuel Bachy, MD PhD, Bohrane Slama, MD, Luc Matthieu Fornecker, Lucie Oberic, MD, Alexandra Traverse-Glehen, MD PhD, Youlia Kirova, MD, Reyal Fabien, MD, Herve Tilly, MD, Emmanuelle Nicolas-Virelizier, MD, Luc Xerri, MD PhD, Philippe Gaulard, MD, Corinne Haioun, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1641.
https://doi.org/10.1182/blood-2018-99-111659
Published: 2018
Journal Articles

BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for Chemosensitive Relapses in Patients with Follicular Lymphoma: A Prospective Multicenter Phase II Study from Lymphoma Study Association (LYSA) Centers

Herv Ghesquieres, Cecile Dalban, MSc, Emmanuelle Nicolas-Virelizier, MD, Fabrice Jardin, MD PhD, Fabien Le Bras, Steven Le Gouill, MD PhD, Rene-Olivier Casasnovas, MD, Seraphine Vizoso, PhD, Caroline Hernandez, MSc, Severine Metzger, MSc, David Perol, MD, Guillaume Cartron
Journal: Blood
Blood (2018) 132 (Supplement 1): 4612.
https://doi.org/10.1182/blood-2018-99-116301
Published: 2018
Journal Articles

Bortezomib and High-Dose Melphalan Vs. High-Dose Melphalan As Conditioning Regimen before Autologous Stem Cell Transplantation in De Novo Multiple Myeloma Patients: A Phase 3 Study of the Intergroupe Francophone Du Myelome (IFM 2014-02)

Murielle Roussel, Benjamin Hebraud, MD, Valerie Lauwers-Cances, MD, Margaret Macro, MD, Xavier Leleu, MD PhD, Cyrille Hulin, MD, Lionel Karlin, MD, Bruno Royer, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Denis Caillot, MD, Sophie Rigaudeau, MD, Mamoun Dib, MD, Emmanuelle Nicolas-Virelizier, MD, Martine Escoffre-Barbe, MD, Karim Belhadj, MD, Brigitte Pegourie, MD, Anne-Marie Stoppa, MD, Carla Araujo, MD, Chantal Doyen, MD, Jean Fontan, MD, Brigitte Kolb, MD, Laurent Garderet, MD PhD, Sabine Brechignac, MD, Jean Valere Malfuson, MD, Veronique Dorvaux, MD, Pascal Lenain, MD, Omar Benbrahim, MD, Arnaud Jaccard, Cecile Borel, MD, Herve Avet Loiseau, MD PhD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 398.
https://doi.org/10.1182/blood.V130.Suppl_1.398.398
Published: 2017
Journal Articles

Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years

Gilles Andre Salles, MD PhD, John Francis Seymour, MBBS, Pierre Feugier, MD, Fritz Offner, MDhD, Armando Lopez-Guillermo, David Belada, MD PhD, Luc Xerri, MD PhD, Reda Bouabdallah, MD, John Catalano, Pauline Brice, MD, Corinne Haioun, Alejandro Martín, MD PhD, Lars Moller Pedersen, Alain Jacques Delmer, MD, David Simpson, MBChB, Sirpa Leppa, MD, Pierre Soubeyran, MD PhD, Rene-Olivier Casasnovas, MD, Tanin Intragumtornchai, MD, Vincent Ribrag, Maria Gomes Silva, Emmanuelle Nicolas-Virelizier, MD, Thomas Lister, MD, Jane Estell, Gustavo Milone, MD, Anne Sonet, MD, Julie Assemat, Harald Zeuner, Bertrand Coiffier, MD PhD, Herve Tilly
Journal: Blood
Blood (2017) 130 (Supplement 1): 486.
https://doi.org/10.1182/blood.V130.Suppl_1.486.486
Published: 2017
Journal Articles

Sequential Lymphoma between Classical Hodgkin Lymphoma and Diffuse Large B Cell Lymphoma: Clinicopathological Characteristics and Outcome of 18 Patients from Lysa Center

Guillaume Aussedat, Hervé Ghesquières, MD PhD, Aspasia Stamatoullas, MD, Pierre Hirsch, MDPhD, Emmanuelle Nicolas-Virelizier, MD, Guillaume Cartron, Caroline Regny, Lionel Karlin, MD, Catherine Chassagne-Clément, MD, Violaine Safar, Nicolas Albin, MD, Antoine Deleuze, Alexis Lambour, Nicolas Daguindau, Christiane Copie, MDPhD, Richard Lemal, MD, Gilles Salles, MD PhD, Alexandra traverse-Glehen, MD PhD, Clementine Sarkozy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4149.
https://doi.org/10.1182/blood.V130.Suppl_1.4149.4149
Published: 2017
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

R-DHA-Oxaliplatin before Autologous Stem Cell Transplantation Prolongs PFS and OS As Compared to R-DHA-Carboplatin and R-DHA-Cisplatin in Patients with Mantle Cell Lymphoma, a Subgroup Analysis of the LyMa Trial

Steven Le Gouill, MD PhD, Catherine Thieblemont, MD PhD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, Gandhi Damaj, MD, Thomas Gastinne, MD, Vincent Ribrag, Carla Araujo, MD, Eric Deconinck, MD PhD, Joel Fleury, MD, Pierre Morel, MD, Emmanuelle Nicolas-Virelizier, MD, Reda Bouabdallah, MD, Jamilé Frayfer, MD, Eric Jourdan, MD, Richard Delarue, MD, Laurence Sahnes, Alain Delmer, Anne Moreau, MD, Marie C Bene, PharmD,DPhil, Gilles Andre Salles, MD PhD, Herve Tilly, Thierry Lamy, Pr, MD PhD, Remy Gressin, MD, Olivier Hermine, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1496.
https://doi.org/10.1182/blood.V130.Suppl_1.1496.1496
Published: 2017